The solution to the AMR problem lies as much with disciplines outside of biomedicine as within it. Thus, a major goal of the AMR Task Force is to engage and […]

This virtual conference will explore the current challenges and treatment opportunities for Gram-negative infections. Delegates will, through plenary lectures and debate, learn about clinical presentations of Gram-negatives and the latest […]

On October 13-14, 2022, the Forum on Drug Discovery, Development, and Translation, the Forum on Medical and Public Health Preparedness for Disasters and Emergencies, and the Forum on Microbial Threats will host a public workshop […]

The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. […]

3 DAYS - 100+ NATIONS - 400+ SPEAKERS - 6,000+ PARTICIPANTS HEALTH FOR ALL IS THE GOAL – WHS 2022 IS THE EVENT #WHS2022 - where science, politics, the private sector […]

ID Week Learning Objectives: Update infectious diseases clinicians, investigators, infection preventionists, and pharmacists with state of- the-art developments in the field, including timely reviews of recent advances in clinical care […]

COVID Update: We are less than 8 weeks away from the H3D 2021 Symposium which was scheduled for 10th – 12th March 2021. Unfortunately, I regret to announce that our […]

Are you an India-based academic, R&D manager or scientist interested in transitioning your #AMR #bacterial #diagnostic into an IVD product? 🖥️ Register for the 5-part seminar series from November 7 through December 9. Topics include: *️ (11 Nov.) Product development process *️ (18 Nov.) Design controls *️ (21 Nov.) Real-life stories: Academia to commercialization *️ […]

The Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR), invites you to participate in our annual conference to learn about U.S. Government medical countermeasure priorities, interact with the BARDA and ASPR teams, and network with public and […]

The outbreak of COVID-19 has not only revealed Japan’s lag in such areas including R&D of domestic vaccines and medicines, digitalization of its medical systems, and crisis management system itself, but also revealed the vulnerability in the global health system. Developing countries are also confronted with infection controls, which results in virus mutation and spread […]